Intervention Review

You have free access to this content

Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction

  1. Taghride Dahhan1,*,
  2. Eva Balkenende2,
  3. Madelon van Wely3,
  4. Sabine Linn4,
  5. Mariëtte Goddijn1

Editorial Group: Cochrane Gynaecology and Fertility Group

Published Online: 8 NOV 2013

Assessed as up-to-date: 16 OCT 2013

DOI: 10.1002/14651858.CD010240.pub2


How to Cite

Dahhan T, Balkenende E, van Wely M, Linn S, Goddijn M. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010240. DOI: 10.1002/14651858.CD010240.pub2.

Author Information

  1. 1

    Academic Medical Center University of Amsterdam, Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands

  2. 2

    Academic Medical Centre, University of Amsterdam, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands

  3. 3

    Academic Medical Center, University of Amsterdam, Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands

  4. 4

    Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam, Netherlands

*Taghride Dahhan, Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Center University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, Netherlands. t.dahhan@amc.uva.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 8 NOV 2013

SEARCH